false
Skip Navigation Links
AOAAM.org
Leadership
Committees
FAQ
Member Search
Mission Statement
Donate
Contact Us
Education
Review Course
Review Course Home
Register
Resources
FAQs
Faculty
Live Q&A Sessions
DEA 8-hour Course
Annual Convention OMED
AOA Addiction Medicine Subspecialty Certification
FAQs
8-Hour MOUD
The 8-hour MOUD Training
NP-PA and Advanced MOUD Trainings
PCSS Mentoring
PCSS News
Clinical Tools
Membership
Join Us - Renew
Events
FAQ
Forums
Member Search
AOAAM Fellow
Members Only
Board Members Only
Resources
General News
Position Papers
Journal of Addictive Diseases
Carrying and Administering of Intranasal Naloxone
Marijuana Pocket Card
Opioid Response Network (ORN)
Useful Links
Students
Career Center
Contact Us
Menu
AOAAM.org
Leadership
Committees
FAQ
Member Search
Mission Statement
Donate
Contact Us
Education
Review Course
DEA 8-hour Course
Annual Convention OMED
AOA Addiction Medicine Subspecialty Certification
FAQs
8-Hour MOUD
The 8-hour MOUD Training
NP-PA and Advanced MOUD Trainings
PCSS Mentoring
PCSS News
Clinical Tools
Membership
Join Us - Renew
Events
FAQ
Forums
Member Search
AOAAM Fellow
Members Only
Board Members Only
Resources
General News
Position Papers
Journal of Addictive Diseases
Carrying and Administering of Intranasal Naloxone
Marijuana Pocket Card
Opioid Response Network (ORN)
Useful Links
Students
Career Center
Contact Us
Hamburger Menu
Catalog
Calendar
Help & FAQ
Catalog
Treatment of Perinatal Opioid Use Disorder via Tel ...
Treatment of Perinatal Opioid Use Disorder via Telemedicine
Description
This is the sixth webinar in the telehealth series for the Opioid Response Network (ORN).
The webinar will describe the use of telemedicine to create integrated mental health and substance use disorder treatment services for pregnant and postpartum women receiving prenatal care in an obstetric setting. The webinar will describe outcomes for pregnant women with Opioid Use Disorder and how technology is being leveraged during COVID-19 to improve detection and treatment of maternal mental health and substance use disorders.
Funding for this initiative was made possible (in part) by grant no. 6H79TI080816 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
(No CME offered for this course.)
Speakers
Constance Guille, MD
Dr. Constance Guille is a Professor in the Department of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at the Medical University of South Carolina (MUSC) and director of the Women’s Reproductive Behavioral Health Division at MUSC. This division provides mental health and substance use disorder treatment to pregnant and postpartum women and conducts clinical research that aims to improve the identification and treatment of peripartum mental health and substance use disorders. Dr. Guille receives research support through National Institute on Drug Abuse and foundations such as the Duke Endowment to develop treatments that leverage technology to improve maternal health.
Julie Kmiec, DO, FAOAAM
Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program.
Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.
Summary
Availability:
Retired
Cost:
FREE
Credit Offered:
No Credit Offered
×
Treatment of Perinatal Opioid Use Disorder via Telemedicine Course List
Create Account
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
Innovation and Regulation: Improving Methadone Access While Maintaining Treatment Quality and Safety
Multiple Credits
FREE
Enduring Activity
Online
(4)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Why Preventing Drug Overdose Deaths is a Moving Target: Dynamic Shifts to the Opioid Crisis by Age, Race, Supply, Demand, and Geography
Multiple Credits
FREE
Enduring Activity
Online
(11)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Isn't There a Better Way? Mitigating the Harms of Criminal Legal Involvement for Pregnant People Who Use Drugs
Multiple Credits
FREE
Enduring Activity
Online
(12)
Learning Activity Title
Learning Activity Title
Learning Activity Title
The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
Multiple Credits
FREE
Enduring Activity
Online
(7)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Update on the U.S. Overdose Crisis: Which drugs, who is dying, and how do we save lives?
Multiple Credits
FREE
Enduring Activity
Online
(12)
Learning Activity Title
Learning Activity Title
Learning Activity Title
New Approaches to Methamphetamine Addiction and Psychosis
Multiple Credits
FREE
Enduring Activity
Online
(8)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Xylazine - An Introduction to a New Drug
Multiple Credits
FREE
Enduring Activity
Online
(13)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Operationalizing a Definition of Precipitated Withdrawal and the Absorption, Distribution, Metabolism, and Elimination of Illicitly Manufactured Fentanyl
Multiple Credits
FREE
Enduring Activity
Online
(15)
Learning Activity Title
Learning Activity Title
Learning Activity Title
Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder
1 AOA Category 1A
FREE
Enduring Activity
Online
(8)
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English